Coprelotamab Antibody
Coprelotamab (GB-221) is a monoclonal IgG1 kappa antibody targeting EGFR2, commonly expressed in CHO DG44 cells. It is utilized in oncology research for investigating EGFR2 signaling pathways in both in vitro cellular assays and in vivo preclinical models.
Product Specifications
Target
HER
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cardiovascular Research, Signal Transduction
Concentration
6.11 mg/mL
Purity
95.00% (May vary between batches)
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
243056-ML405 100 µL
ACTA2 (Actin, alpha 2, Smooth Muscle, aorta, AAT6, ACTSA) (MaxLight 405) discontinued
Sign In for Pricing
View Details 
MBS1085774-01 0.02 mg (E-Coli)
Recombinant Azoarcus sp. Indole-3-glycerol phosphate synthase (trpC)
Sign In for Pricing
View Details MBS1085774-02 0.02 mg (Yeast)
Recombinant Azoarcus sp. Indole-3-glycerol phosphate synthase (trpC)
Sign In for Pricing
View Details MBS1085774-03 0.1 mg (E-Coli)
Recombinant Azoarcus sp. Indole-3-glycerol phosphate synthase (trpC)
Sign In for Pricing
View Details MBS1085774-04 0.1 mg (Yeast)
Recombinant Azoarcus sp. Indole-3-glycerol phosphate synthase (trpC)
Sign In for Pricing
View Details MBS1085774-05 0.02 mg (Baculovirus)
Recombinant Azoarcus sp. Indole-3-glycerol phosphate synthase (trpC)
Sign In for Pricing
View Details